Request for Support: Translating to practical use

The CiRA Foundation was founded in 2020 to operate the iPS Cell Stock Project and advance related regenerative medicine. The CiRA Foundation succeeds the Center for iPS Cell Research and Application (CiRA), Kyoto University in this role, which includes the manufacturing and storage of high quality iPS cells for distribution to research centers and companies developing clinical applications. Currently, the CiRA Foundation is primarily funded by the iPS Cell Research Fund.

Your support therefore aids in recruiting and retaining talented staff who will help achieve its goals. To further the application and commercialization of iPS cells for regenerative medicine, the CiRA Foundation maintains a strong relationship with CiRA. We appreciate your support.